Fervent Synerg.

Which are the latest news on Fervent Synerg.?

Why is Fervent Synergies Ltd falling/rising?

As of 05-Sep, Fervent Synergies Ltd's stock price is slightly rising at 15.02, but it has significant declines year-to-date and over the past year. Despite today's outperformance against the sector, overall investor sentiment remains weak with declining participation.

As of 05-Sep, Fervent Synergies Ltd's stock price is rising slightly, with a current price of 15.02, reflecting a change of 0.02 (0.13%) upwards. This increase in price today is notable as it has outperformed the sector by 0.45%. However, despite this minor rise, the stock has experienced significant declines over longer periods, with a year-to-date decrease of 20.02% and a one-year decline of 36.76%. <BR><BR>The stock's performance relative to the benchmark, the Sensex, shows that while it has outperformed the sector today, it has underperformed over the past week, month, year, and three years. Additionally, there is a concerning trend of falling investor participation, as indicated by a delivery volume drop of 34.37% compared to the five-day average. This suggests that while there may be a slight uptick in price today, the overall sentiment towards the stock remains weak, with liquidity being sufficient for trading but not robust enough to indicate strong investor confidence.

Who are in the management team of Fervent Synerg.?

The management team of Fervent Synerg includes Vijay P Thakkar (Chairman, CEO), Karan V Thakkar (CFO), Sanjay P Thakkar (Managing Director), and independent directors Nitin B Parikh, Rajesh M Maheshwari, and Falguni Kaushik Mehta.

The management team of Fervent Synerg includes the following individuals:<BR><BR>1. **Vijay P Thakkar** - Chairman, Executive Director, and CEO<BR>2. **Karan V Thakkar** - Executive Director and Chief Financial Officer<BR>3. **Sanjay P Thakkar** - Executive Director, Managing Director, and Promoter<BR>4. **Nitin B Parikh** - Independent Non-Executive Director<BR>5. **Rajesh M Maheshwari** - Independent Non-Executive Director<BR>6. **Falguni Kaushik Mehta** - Independent Non-Executive Director<BR><BR>If you need more details about any specific member or their roles, feel free to ask!

What does Fervent Synerg. do?

Fervent Synergies Ltd, a Micro Cap company in the Trading & Distributors industry, reported net sales of 1 Cr and a net profit of 0 Cr for June 2026. It was incorporated in 2009 and has a market cap of INR 75 Cr, with a P/E ratio of 21.00.

Overview:<BR>Fervent Synergies Ltd operates in the Trading & Distributors industry and is classified as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in 2009 as Fervent Pharma Synergies Limited and changed its name to Fervent Synergies Limited on July 24, 2012. The most recent quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 1 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 0 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 75 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 21.00 <BR>Industry P/E: 37 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.01 <BR>Return on Equity: 6.37% <BR>Price to Book: 1.31 <BR><BR>Contact Details:<BR>Address: B-7/8 Satyam Commercial Comple, M G Road Ghatkopar (East) Mumbai Maharashtra : 400077 <BR>Tel: 91-22-25017801/02/03 <BR>Email: info@ferventsynergies.com <BR>Website: http://www.ferventsynergies.com

Who are the peers of the Fervent Synerg.?

Fervent Synerg.'s peers include Variman Global, Cravatex, Confidence Fut., Dhanlaxmi Cotex, Ashnisha Indus., Sunrise Efficie., Eforu Entertainm, Chandni Machines, and Ganesha Ecoverse. Fervent Synerg. has below average management and capital structure, with a 1-year return of -35.96%, better than Variman Global but lower than most peers.

Peers: The peers of Fervent Synerg. are Variman Global, Cravatex, Confidence Fut., Dhanlaxmi Cotex, Ashnisha Indus., Sunrise Efficie., Eforu Entertainm, Chandni Machines, and Ganesha Ecoverse.<BR><BR>Quality Snapshot: Below Average management risk is observed at Variman Global, Confidence Fut., Fervent Synerg., Dhanlaxmi Cotex, Ashnisha Indus., Eforu Entertainm, and Ganesha Ecoverse, while Average management risk is found at Cravatex, Sunrise Efficie., and Chandni Machines. Good growth is noted at Confidence Fut. and Fervent Synerg., while Average growth is seen at Variman Global, Sunrise Efficie., and the rest. Excellent capital structure is present at Variman Global and Dhanlaxmi Cotex, while Below Average capital structure is found at Cravatex, Confidence Fut., Fervent Synerg., Ashnisha Indus., Eforu Entertainm, Ganesha Ecoverse, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Chandni Machines at 172.74%, while the lowest is Variman Global at -65.07%. Fervent Synerg.'s 1-year return is -35.96%, which is higher than Variman Global's but lower than the majority of its peers. Additionally, peers with a negative six-month return include Variman Global, Confidence Fut., Ashnisha Indus., Sunrise Efficie., and Ganesha Ecoverse.

How big is Fervent Synerg.?

As of 31st August, Fervent Synergies Ltd has a market capitalization of 75.00 Cr, with recent net sales of 16.40 Cr and a net profit of 3.64 Cr. The latest balance sheet shows shareholder's funds of 57.15 Cr and total assets of 58.09 Cr.

As of 31st August, Fervent Synergies Ltd has a market capitalization of 75.00 Cr, which classifies it as a Micro Cap company.<BR><BR>In the latest four quarters, Fervent Synergies Ltd reported Net Sales of 16.40 Cr and a Net Profit of 3.64 Cr.<BR><BR>The latest annual period for the balance sheet is March 2026, showing Shareholder's Funds of 57.15 Cr and Total Assets of 58.09 Cr.

Are Fervent Synergies Ltd latest results good or bad?

Fervent Synergies Ltd's latest results are concerning, with a 77.01% decline in net profit and an 85.77% drop in revenue compared to the previous quarter, indicating significant operational challenges and a deteriorating financial situation. Despite a slight year-on-year revenue growth of 8.82%, the overall performance is classified as bad.

Fervent Synergies Ltd's latest results are concerning and can be classified as bad. In Q1 FY27, the company reported a net profit of ₹0.20 crores, which represents a significant decline of 77.01% compared to the previous quarter. Revenue also plummeted to ₹0.74 crores, marking an 85.77% decrease quarter-on-quarter and indicating the lowest quarterly sales performance on record.<BR><BR>While there was a slight year-on-year revenue growth of 8.82% from ₹0.68 crores in Q1 FY26, this is minimal and does not offset the severe decline observed in the most recent quarter. The company's operating profit margin did improve to 33.78%, but this improvement is overshadowed by the drastic drop in revenue and net profit.<BR><BR>Additionally, the return on equity (ROE) stands at a weak 2.69%, which is below average for the sector, indicating inefficiencies in generating returns for shareholders. The volatility in revenue, which has fluctuated dramatically over recent quarters, raises serious concerns about the sustainability of the business model.<BR><BR>Overall, the financial performance of Fervent Synergies Ltd in the latest results reflects significant operational challenges and a deteriorating financial situation.

Should I buy, sell or hold Fervent Synergies Ltd?

When is the next results date for Fervent Synergies Ltd?

The next results date for Fervent Synergies Ltd is February 5, 2026.

The next results date for Fervent Synergies Ltd is scheduled for February 5, 2026.

Is Fervent Synerg. overvalued or undervalued?

As of December 2, 2025, Fervent Synerg. is fairly valued with a PE ratio of 25.56 and a PEG ratio of 0.22, making it more attractive compared to peers like Sun Pharma and Divi's Lab, despite recent underperformance against the Sensex.

As of 2 December 2025, Fervent Synerg. has moved from an expensive to a fair valuation grade. The company is currently fairly valued based on its financial metrics, with a PE ratio of 25.56, an EV to EBITDA ratio of 25.36, and a PEG ratio of 0.22. These ratios indicate a more reasonable valuation compared to its peers.<BR><BR>In comparison to its industry peers, Fervent Synerg. stands out with a lower PE ratio than Sun Pharma. Industries, which has a PE of 37.36, and Divi's Lab., which is at 68.62. Additionally, Fervent's PEG ratio of 0.22 is significantly more attractive than that of its competitors, suggesting potential for growth relative to its price. Despite recent underperformance against the Sensex, with a 1-week return of -16.21% compared to the Sensex's 0.65%, the current valuation appears justified given the overall market context.

How has been the historical performance of Fervent Synerg.?

Fervent Synerg. has shown significant revenue growth, with net sales increasing from 0.68 Cr in Mar'22 to 32.46 Cr in Mar'25, and a return to profitability with a profit after tax of 2.95 Cr in Mar'25. However, the company still faces negative cash flow from operating activities at -15.00 Cr in Mar'25.

Answer:<BR>The historical performance of Fervent Synerg. shows significant fluctuations in its financial metrics over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Fervent Synerg. has experienced a notable increase in net sales, rising from 0.68 Cr in Mar'22 to 32.46 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar trend, reaching 32.46 Cr in Mar'25 compared to just 0.68 Cr in Mar'22. However, total expenditure peaked at 37.07 Cr in Mar'24 before decreasing to 29.47 Cr in Mar'25, which contributed to an operating profit of 2.99 Cr in Mar'25, a significant recovery from the loss of 12.76 Cr in the previous year. Profit before tax also improved to 2.95 Cr in Mar'25 from a loss of 12.85 Cr in Mar'24, leading to a profit after tax of 2.95 Cr in Mar'25, compared to a loss of 12.84 Cr in Mar'24. The company's equity capital increased to 43.75 Cr in Mar'25 from 30.00 Cr in Mar'24, and total assets rose to 48.78 Cr in Mar'25 from 30.51 Cr in Mar'24. Despite these improvements, the cash flow from operating activities remained negative at -15.00 Cr in Mar'25, indicating challenges in cash generation despite profitability. Overall, while Fervent Synerg. has shown strong revenue growth and a return to profitability, it faces ongoing cash flow issues.

What is the technical trend for Fervent Synerg.?

As of May 22, 2025, Fervent Synerg's technical trend is mildly bullish, supported by daily moving averages and a bullish monthly MACD, despite mixed signals from the weekly MACD and Bollinger Bands.

As of 22 May 2025, the technical trend for Fervent Synerg has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, indicating mixed signals. The daily moving averages suggest a mildly bullish stance, contrasting with the weekly Bollinger Bands, which are mildly bearish. The KST shows a bearish trend on the weekly chart but bullish on the monthly. Overall, the lack of clear trends in Dow Theory and the neutral signals from the RSI suggest a cautious outlook. The current technical stance is mildly bullish, driven primarily by the daily moving averages and the monthly MACD.

Who are the top shareholders of the Fervent Synerg.?

The top shareholder of Fervent Synerg is Vijay Thakkar, with a 57.49% stake. Other notable shareholders include Blue Berry Securities Pvt Ltd at 5.66% and individual investors with a combined 8.44%.

The top shareholders of Fervent Synerg include Vijay Thakkar, who holds the largest stake at 57.49%. The company is primarily owned by its promoters, with no pledged promoter holdings reported. The highest public shareholder is Blue Berry Securities Pvt Ltd, which holds 5.66%. Additionally, individual investors collectively own 8.44% of the company. There is also one Foreign Institutional Investor (FII) involved, but they hold a negligible percentage of 0.0%.

Has Fervent Synerg. declared dividend?

No Dividend History Available